🇧🇪·3d agoDevices
UCB presents new BIMZELX[®] (bimekizumab-bkzx) data at AAD demonstrating high rates of durable and...
Publisher
U
UCB
Belgium
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on ucb.com
Leave the platform to read the original full article on the publisher site.
Source: UCB
Scope: Devices
Related coverage
More related coverage
Hitachi Medical Systems News·10h ago
Mar 30, 2026MOL and Hitachi Launch Initiative to Convert Used Ships into Floating Data CentersNew
ICON plc·1d ago
Industry events
Fujirebio·2d ago
Mar 28, 2026-Mar 28, 2026VVN 2026 - Vlaamse Vereniging voor NeurologieGhent,BelgiumMore info and meet us there
Boston Scientific News·2d ago
CHAMPION-AF study of the WATCHMAN FLX™ Left Atrial Appendage Closure Device as a first-line therapy for stroke risk reduction meets all primary and secondary safety and efficacy endpoints
At Boston Scientific, unwavering commitment to patients translates into the highest levels of resear...